EMA CONSULTATION
May 1st, 2004
BY KEITH NUTHALLTHE NEWLY renamed European Medicines Agency (EMA) has launched asked for comments on a 'road map to 2010: preparing the ground for the future'. It outlines the agency's strategy to "further develop as one of the world's foremost regulatory authorities for medicinal products, which is public health oriented, science-driven and transparent". The paper focuses on EMA twin approach, to better protect and inform patients, whilst encouraging innovation and research in an enlarged European Union (EU). It says the agency will stress its duties towards ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.